{
  "projects": [
    { "id": "proj_pcdrug", "name": "PCDRUG Program", "compound": "PCDRUG", "cas": "123456-78-9", "phase": "IND-Enabling", "therapeutic_area": "Oncology" },
    { "id": "proj_axl42", "name": "AXL-42 Program", "compound": "AXL-42", "cas": "987654-32-1", "phase": "Lead Optimization", "therapeutic_area": "Inflammation" }
  ],
  "studies": [
    {
      "id": "PC201708",
      "project": "proj_pcdrug",
      "test_article": "PCDRUG",
      "title": "13-Week Repeat Dose Toxicity Study on PCDRUG in Rats",
      "protocol": "PC-2017-TOX-08",
      "species": "Rat",
      "strain": "Sprague Dawley",
      "route": "ORAL GAVAGE",
      "study_type": "Repeat Dose Toxicity",
      "duration_weeks": 13,
      "recovery_weeks": 2,
      "doses": [0, 2, 20, 200],
      "dose_unit": "mg/kg/day",
      "subjects": 150,
      "pipeline_stage": "submitted",
      "submission_date": "2018-03-15",
      "status": "Complete",
      "has_nsdrg": true,
      "has_define": true,
      "has_xpt": true,
      "target_organs_reported": ["LIVER"],
      "target_organs_derived": ["LIVER", "HEMATOPOIETIC SYSTEM"],
      "noael_reported": { "dose": 2, "unit": "mg/kg/day", "basis": "BW decrease and hepatic microscopic findings at 20 mg/kg/day" },
      "noael_derived": { "dose": 2, "unit": "mg/kg/day", "method": "Williams' test + histopath incidence" },
      "loael_reported": { "dose": 20, "unit": "mg/kg/day" },
      "loael_derived": { "dose": 20, "unit": "mg/kg/day" },
      "key_findings_reported": "Decreased BW at ≥20 mg/kg/day. Liver enzyme elevations (ALT, AST, ALP), decreased RBC/HGB/HCT, increased liver weights, hepatic macro/micro findings at 200 mg/kg/day. Hepatocellular neoplasms and mortality at 200 mg/kg/day. Partial recovery of liver findings at 20 mg/kg/day.",
      "domains": ["TA","TE","TS","TX","CO","DM","SE","EX","DS","BG","BW","CL","DD","EG","FW","LB","MA","MI","OM","PC","PM","PP","SC","TF","VS","RELREC","SUPPMA","SUPPMI"],
      "domains_planned": null,
      "domains_collected": null,
      "validation": { "errors": 0, "warnings": 942, "all_addressed": true },
      "findings": {
        "BW": { "groups": [3,4], "direction": "↓", "params": ["BW","BWGAIN"], "recovery": "partial", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "LB": { "groups": [4], "direction": "↑", "params": ["ALT","AST","ALP"], "recovery": "partial", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "LB_HEM": { "groups": [4], "direction": "↓", "params": ["RBC","HGB","HCT"], "recovery": "partial", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "OM": { "groups": [4], "direction": "↑", "params": null, "recovery": null, "specimen": "LIVER", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "MA": { "groups": [3,4], "direction": null, "params": null, "recovery": null, "specimen": "LIVER", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "MI": { "groups": [3,4], "direction": null, "params": null, "recovery": null, "specimen": "LIVER", "severity": {"3": "minimal-mild", "4": "mild-moderate"}, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "TF": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": "LIVER", "severity": null, "types": ["Hepatocellular adenoma","Hepatocellular carcinoma"], "cause": null, "count": null, "sex": null, "note": null },
        "DD": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": null, "severity": null, "types": null, "cause": "Hepatocellular carcinoma", "count": 3, "sex": null, "note": null }
      },
      "interim_observations": null,
      "design_rationale": null
    },
    {
      "id": "PC201802",
      "project": "proj_pcdrug",
      "test_article": "PCDRUG",
      "title": "4-Week Dose Range Finding Study on PCDRUG in Beagle Dogs",
      "protocol": "PC-2018-TOX-02",
      "species": "Dog",
      "strain": "Beagle",
      "route": "ORAL CAPSULE",
      "study_type": "Repeat Dose Toxicity",
      "duration_weeks": 4,
      "recovery_weeks": 4,
      "doses": [0, 1, 5, 25],
      "dose_unit": "mg/kg/day",
      "subjects": 20,
      "pipeline_stage": "submitted",
      "submission_date": "2019-01-22",
      "status": "Complete",
      "has_nsdrg": true,
      "has_define": true,
      "has_xpt": true,
      "target_organs_reported": ["LIVER", "KIDNEY"],
      "target_organs_derived": ["LIVER", "KIDNEY"],
      "noael_reported": { "dose": 5, "unit": "mg/kg/day", "basis": "ALT/AST elevations and renal tubular basophilia at 25 mg/kg/day" },
      "noael_derived": { "dose": 5, "unit": "mg/kg/day", "method": "Dunnett's test" },
      "loael_reported": { "dose": 25, "unit": "mg/kg/day" },
      "loael_derived": { "dose": 25, "unit": "mg/kg/day" },
      "key_findings_reported": "Minimal ALT/AST elevations at 25 mg/kg/day (adaptive, no histopathological correlate in liver). Renal tubular basophilia at 25 mg/kg/day in males only. All findings fully reversible.",
      "domains": ["TA","TE","TS","TX","CO","DM","SE","EX","DS","BG","BW","CL","EG","FW","LB","MA","MI","OM","SC","VS"],
      "domains_planned": null,
      "domains_collected": null,
      "validation": { "errors": 0, "warnings": 412, "all_addressed": true },
      "findings": {
        "BW": { "groups": [4], "direction": "↓", "params": ["BWGAIN"], "recovery": "full", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "LB": { "groups": [4], "direction": "↑", "params": ["ALT","AST"], "recovery": "full", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": "<2x control" },
        "MI_kidney": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": "KIDNEY", "severity": null, "types": null, "cause": null, "count": null, "sex": "males only", "note": null }
      },
      "interim_observations": null,
      "design_rationale": null
    },
    {
      "id": "PC201905",
      "project": "proj_pcdrug",
      "test_article": "PCDRUG",
      "title": "26-Week Repeat Dose Toxicity Study on PCDRUG in Beagle Dogs",
      "protocol": "PC-2019-TOX-05",
      "species": "Dog",
      "strain": "Beagle",
      "route": "ORAL CAPSULE",
      "study_type": "Repeat Dose Toxicity",
      "duration_weeks": 26,
      "recovery_weeks": 4,
      "doses": [0, 1, 3, 10],
      "dose_unit": "mg/kg/day",
      "subjects": 24,
      "pipeline_stage": "pre_submission",
      "submission_date": null,
      "status": "Complete",
      "has_nsdrg": true,
      "has_define": true,
      "has_xpt": true,
      "target_organs_reported": ["LIVER"],
      "target_organs_derived": ["LIVER", "ADRENAL"],
      "noael_reported": { "dose": 3, "unit": "mg/kg/day", "basis": "Hepatocellular hypertrophy and ALT elevation at 10 mg/kg/day" },
      "noael_derived": { "dose": 1, "unit": "mg/kg/day", "method": "Williams' test — BW decrease at 3 mg/kg/day flagged as statistically significant" },
      "loael_reported": { "dose": 10, "unit": "mg/kg/day" },
      "loael_derived": { "dose": 3, "unit": "mg/kg/day" },
      "key_findings_reported": "Minimal ALT elevations at 10 mg/kg/day. Minimal centrilobular hepatocellular hypertrophy at 10 mg/kg/day (enzyme induction). Fully reversible. No BW, food consumption, or hematology effects considered treatment-related.",
      "domains": ["TA","TE","TS","TX","CO","DM","SE","EX","DS","BG","BW","CL","EG","FW","LB","MA","MI","OM","SC","VS"],
      "domains_planned": null,
      "domains_collected": null,
      "validation": { "errors": 0, "warnings": 298, "all_addressed": true },
      "findings": {
        "BW": { "groups": [3,4], "direction": "↓", "params": ["BW"], "recovery": "full", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": "Statistically significant at 3 mg/kg/day but considered non-adverse by study director" },
        "LB": { "groups": [4], "direction": "↑", "params": ["ALT"], "recovery": "full", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": "<1.5x control" },
        "MI": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": "LIVER", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "MI_adrenal": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": "ADRENAL", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": "Minimal vacuolation, not listed as target organ in study report" }
      },
      "interim_observations": null,
      "design_rationale": null
    },
    {
      "id": "PC202103",
      "project": "proj_pcdrug",
      "test_article": "PCDRUG",
      "title": "13-Week Repeat Dose Toxicity Study on PCDRUG in Beagle Dogs",
      "protocol": "PC-2021-TOX-03",
      "species": "Dog",
      "strain": "Beagle",
      "route": "ORAL CAPSULE",
      "study_type": "Repeat Dose Toxicity",
      "duration_weeks": 13,
      "recovery_weeks": 4,
      "doses": [0, 0.5, 2, 8],
      "dose_unit": "mg/kg/day",
      "subjects": 32,
      "pipeline_stage": "ongoing",
      "submission_date": null,
      "status": "In-Life",
      "has_nsdrg": false,
      "has_define": false,
      "has_xpt": true,
      "target_organs_reported": null,
      "target_organs_derived": null,
      "noael_reported": null,
      "noael_derived": null,
      "loael_reported": null,
      "loael_derived": null,
      "key_findings_reported": null,
      "domains": null,
      "domains_planned": ["TA","TE","TS","TX","DM","SE","EX","DS","BG","BW","CL","EG","FW","LB","MA","MI","OM","SC","VS"],
      "domains_collected": ["DM","BW","CL","FW","EX"],
      "validation": null,
      "findings": null,
      "interim_observations": "Week 8: No clinical signs. BW within normal range across all groups. One unscheduled death (Group 1, gavage error — non-treatment related).",
      "design_rationale": null
    },
    {
      "id": "PC202201",
      "project": "proj_pcdrug",
      "test_article": "PCDRUG",
      "title": "Embryo-Fetal Development Study on PCDRUG in Rats",
      "protocol": "PC-2022-REP-01",
      "species": "Rat",
      "strain": "Sprague Dawley",
      "route": "ORAL GAVAGE",
      "study_type": "Reproductive Toxicity",
      "duration_weeks": 3,
      "recovery_weeks": 0,
      "doses": [0, 2, 10, 50],
      "dose_unit": "mg/kg/day",
      "subjects": 88,
      "pipeline_stage": "planned",
      "submission_date": null,
      "status": "Protocol Finalized",
      "has_nsdrg": false,
      "has_define": false,
      "has_xpt": false,
      "target_organs_reported": null,
      "target_organs_derived": null,
      "noael_reported": null,
      "noael_derived": null,
      "loael_reported": null,
      "loael_derived": null,
      "key_findings_reported": null,
      "domains": null,
      "domains_planned": ["TA","TE","TS","TX","DM","SE","EX","DS","BW","CL","FW","MA","MI","SC","TF"],
      "domains_collected": null,
      "validation": null,
      "findings": null,
      "interim_observations": null,
      "design_rationale": "High dose (50 mg/kg/day) at 2.5x rat NOAEL from PC201708. Mid dose at approximate rat LOAEL. Low dose at rat NOAEL."
    },
    {
      "id": "AX220401",
      "project": "proj_axl42",
      "test_article": "AXL-42",
      "title": "28-Day Repeat Dose Toxicity Study on AXL-42 in Rats",
      "protocol": "AX-2022-TOX-04",
      "species": "Rat",
      "strain": "Sprague Dawley",
      "route": "SUBCUTANEOUS",
      "study_type": "Repeat Dose Toxicity",
      "duration_weeks": 4,
      "recovery_weeks": 2,
      "doses": [0, 5, 25, 100],
      "dose_unit": "mg/kg/week",
      "subjects": 80,
      "pipeline_stage": "submitted",
      "submission_date": "2023-08-14",
      "status": "Complete",
      "has_nsdrg": true,
      "has_define": true,
      "has_xpt": true,
      "target_organs_reported": ["INJECTION SITE", "SPLEEN"],
      "target_organs_derived": ["INJECTION SITE", "SPLEEN"],
      "noael_reported": { "dose": 25, "unit": "mg/kg/week", "basis": "Injection site findings and splenic extramedullary hematopoiesis at 100 mg/kg/week" },
      "noael_derived": { "dose": 25, "unit": "mg/kg/week", "method": "Histopathology incidence analysis" },
      "loael_reported": { "dose": 100, "unit": "mg/kg/week" },
      "loael_derived": { "dose": 100, "unit": "mg/kg/week" },
      "key_findings_reported": "Injection site reactions at all doses (dose-related severity). Splenic extramedullary hematopoiesis at 100 mg/kg/week. Transient lymphocyte decrease at 100 mg/kg/week (pharmacology-related). All findings fully reversible.",
      "domains": ["TA","TE","TS","TX","CO","DM","SE","EX","DS","BG","BW","CL","FW","LB","MA","MI","OM","SC","VS"],
      "domains_planned": null,
      "domains_collected": null,
      "validation": { "errors": 0, "warnings": 220, "all_addressed": true },
      "findings": {
        "CL": { "groups": [1,2,3,4], "direction": null, "params": null, "recovery": null, "specimen": "INJECTION SITE", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "MI_inj": { "groups": [2,3,4], "direction": null, "params": null, "recovery": null, "specimen": "INJECTION SITE", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "MI_spl": { "groups": [4], "direction": null, "params": null, "recovery": null, "specimen": "SPLEEN", "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null },
        "LB": { "groups": [4], "direction": "↓", "params": ["LYM"], "recovery": "full", "specimen": null, "severity": null, "types": null, "cause": null, "count": null, "sex": null, "note": null }
      },
      "interim_observations": null,
      "design_rationale": null
    }
  ]
}
